Technophage, SA logo

Technophage, SA

From Science to Innovative Biopharmaceuticals in Infection, Neuroscience and Ophthalmology

28 employees · est. 2005 · Portugal

VS
Transcenta logo

Transcenta

INNOVATE TO EXCEL

94 employees · est. 2019 · Princeton, United States

Technophage, SA is the older company (2005 vs 2019); Transcenta is the larger of the two.

Side-by-Side Comparison

Technophage, SA Transcenta
Founded
2005 older 2019
Headquarters
Portugal Princeton, United States
Employees
28 94 larger
Industry
Biopharma, Biotechnology Not tracked yet
Funding Stage
Not tracked yet IPO
Total Funding
Not tracked yet $178.74M
Funding Rounds
Not tracked yet 5
Services
Development of biological and chemical products, Clinical Trials, GMP Manufacturing, Research and Development Biological Product Development, Antibody Generation, Clinical Research, Biotechnology Manufacturing, Partnering and Licensing
Target Customers
Patients, Investors, Healthcare Professionals Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers, Research Institutions, Global Healthcare Industry
Taxonomy
Biopharmaceuticals, Biological Molecules, Infection Therapeutics, Neuroscience Therapeutics, Ophthalmology Therapeutics, GMP Production, Bacteriophage Therapeutics, Antibody Fragments, Preclinical Development, Clinical Trials, Small Domain Antibodies, R&D Collaborations, Process Development, Screening Platforms In Zebrafish, Innovation In Biotechnology Biopharmaceutical, Antibody Biotherapeutics, Clinical Stage, Oncology, Bone Disorders, Kidney Disorders, Drug Discovery, R&D, Biomanufacturing, Translational Research, Process Development, Therapeutic Antibodies, Clinical Development, External Partnering, Mergers And Acquisitions
Website
technophage.pt transcenta.com
Technophage, SA logo

About Technophage, SA

Technophage, SA, founded in 2005, is a pioneering force in biopharmaceutical innovation, focusing on the R&D of biological molecules in infection, neuroscience, and ophthalmology. With a strategic directive embodied in its slogan—"From Science to Innovative Biopharmaceuticals in Infection, Neuroscie...

Transcenta logo

About Transcenta

Transcenta, with the slogan INNOVATE TO EXCEL, is a clinical-stage biopharmaceutical company committed to the full integration of antibody-based biotherapeutics discovery, research, development, and manufacturing. Founded in 2019, Transcenta has made significant strides in the industry, solidifying...

We will tell you when either one moves

BounceWatch watches Technophage, SA and Transcenta for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Technophage, SA and Transcenta — by email.

Frequently Asked Questions

Technophage, SA — From Science to Innovative Biopharmaceuticals in Infection, Neuroscience and Ophthalmology. Transcenta — INNOVATE TO EXCEL. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Technophage, SA has raised undisclosed funding while Transcenta has raised $178.74M.
Technophage, SA and Transcenta operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Technophage, SA with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Technophage, SA on 15 Jun 2026, and Transcenta on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy